Delivery Order SPE2DB22D9151-SPE2DB23FM8HD
Award Date 5/1/23
Potential Completion Date 5/22/23
Potential Value $28K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $27,853.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from August 23, 2023 through September 14, 2023, with all work to be conducted by DMS Pharmaceutical Group at its facility located in Park Ridge, Illinois. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports Department of Defense procurement through contracts...
- The Defense Logistics Agency awarded a $6,264 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from September 26, 2023 through October 18, 2023, with place of performance in Park Ridge, Illinois. As the DLA supports military readiness by procuring and providing nearly all consumable items for the military services, this delivery order is likely associated with the agency's medical supply program...
- The Defense Logistics Agency awarded a $27,853.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from February 27, 2023 through March 20, 2023, with all work to be completed in Park Ridge, Illinois. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military services and combatant commands. This delivery order was likely...
- The Defense Logistics Agency awarded a $30,948 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from July 25, 2023 through August 15, 2023, with all work to be conducted by DMS Pharmaceutical Group at its facility located in Park Ridge, Illinois. As the DLA supports procurement for the Department of Defense, this delivery order is likely associated with the agency's medical supply contracts...
- The Defense Logistics Agency awarded a $18,568.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from May 26, 2023 through June 20, 2023, with place of performance in Park Ridge, Illinois. As the DLA supports military readiness through logistics solutions, this delivery order was likely placed to supply the asthma medication Xolair to military treatment facilities within the stated timeframe. No...
- The Defense Logistics Agency awarded a $27,853.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from July 25, 2023 through August 15, 2023, with all work to be performed in Park Ridge, Illinois. The DLA supports Department of Defense procurement and supply chain management, and this small contract will deliver an asthma medication to likely support military treatment facilities in the region....
- The Defense Logistics Agency awarded a $15,474 delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/1.2 ml powder vials. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DOD customers. Performance will take place in Park Ridge, Illinois over a one month period concluding in mid-July 2023. No set aside designation or subcontractors were identified. The DLA procures vital medical...
- The Defense Logistics Agency awarded a $27,853.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from June 21, 2023 through July 13, 2023, with all work to be conducted by DMS Pharmaceutical Group at its facility located in Park Ridge, Illinois. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the global supply chain for the United States...
- The Defense Logistics Agency awarded a $30,948 delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/1.2 ml powder vials. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DOD customers. Park Ridge, Illinois is the place of performance for delivery of the medication by September 29th, following a start date of September 8th, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $9,284.40 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from June 9, 2023 through July 3, 2023, with all work to be conducted by DMS Pharmaceutical Group at its facility located in Park Ridge, Illinois. As a component of the Department of Defense, the Defense Logistics Agency supports America's armed forces by procuring nearly $50 billion worth of...
- SPE2DB22D9151Indefinite Delivery Contract
- SPE2DB22D9151-SPE2DB23FM8HDDelivery Order
The Defense Logistics Agency awarded a $27,853.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from May 1, 2023 through May 22, 2023, with place of performance in Park Ridge, Illinois. As the DLA supports the Department of Defense by procuring food, clothing, medicines, fuel and other supplies, this delivery order is likely associated with the agency's medical product procurement programs and will deliver the specified pharmaceutical to support DoD needs. No subcontractors or set aside designations were indicated.
Generated 12/30/23, 3:19 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.9k | 5/1/23 |